CN Stock MarketDetailed Quotes

688089 Cabio Biotech(Wuhan)

Watchlist

25.12
-0.60-2.33%

Market Closed Mar 28 15:00 CST

4.23BMarket Cap34.04P/E (TTM)

Cabio Biotech(Wuhan) Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Cabio Biotech(Wuhan) Q4 2024 Earnings Date

Currency：CNYMar 28, 2025

	Estimate (YoY)	Actual (YoY)	Vs Estimate (% Chg)
Revenue	--	168.45M	--
		+41.58%
Net Income	--	38.97M	--
		+33.27%

Analyst Rating

Strong Buy

Mar 30, 2025

Cabio Biotech(Wuhan) Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2022/Q4	160.180M / 131.000M	--

DatePeriodRevenue/EstimateEarnings Call

--2022/Q4160.180M / 131.000M--

Cabio Biotech(Wuhan) Earnings Reports

Jia Biyou: Summary of the 2024 Annual Report of Jia Biyou Biotechnology (Wuhan) Co., Ltd.

Mar 27 12:00 ET

Jia Biyou: Jia Biyou Biotechnology (Wuhan) Co., Ltd. 2024 Annual Report

Mar 27 12:00 ET

Cabio Biotech(Wuhan) Co., Ltd. 2024 Annual Report

Mar 27 12:00 ET

Cabio Biotech (Wuhan) Co., Ltd. Summary of the Annual Report for 2024.

Mar 27 12:00 ET

Top CN Stock Gainers

Symbol Price % Chg

Shenzhen Kaifa Technology

920029

76.06 +150.36%

Shanghai Yongli Belting

300230

5.93 +20.04%

Guomai Culture & Media

301052

33.42 +20.00%

WuHan Hvsen Biotechnology

See the daily top gainer.

Analysis

Analyst Rating

Updated: Mar 30, 2025

Strong Buy

Strong Buy
88.89%
Buy
11.11%
Hold
0.00%
Underperform
0.00%
Sell
0.00%

Price Target

No Data

Investment Theme

Finance and Securities Lending

Intraday-0.72%

Transferring Securities of Securities

Intraday-0.72%